https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/brc-researchers-develop-new-rapid-test-alzheimer-s-and-lewy-body-dementia/
BRC researchers develop a new rapid test for Alzheimer’s and Lewy Body Dementia
18 Dec 2015, 1:29 p.m.
National Institute for Health Research (NIHR) Great Ormond Street Hospital (GOSH) BRC (Biomedical Research Centre) researchers, working in collaboration with the BRC at NIHR Queen Square Dementia and the Wolfson Biomarker Dementia consortium at Institute of Neurology (IoN), have developed a new test to diagnose different types of dementia, which they hope will allow for more reliable and accurate diagnosis of the neurodegenerative conditions of Lewy Body Dementia and Alzheimer’s disease.These findings have just been accepted for publication in the Journal, Molecular Neurodegeneration.
Currently there are no effective treatments/cures for many neurodegenerative diseases. Reliable biomarkers for identifying and stratifying these diseases will be important in the development of future novel therapies. Lewy Body Dementia (LBD) is considered an under diagnosed form of dementia for which markers are needed to discriminate LBD from other forms of dementia such as Alzheimer’s Disease (AD).
Using a very small amount of Cerebral Spinal Fluid (CSF), the team identified several new protein biomarkers that are increased in LBD patients when compared to healthy controls. Using this, as well as previously identified protein markers, the team developed a 10 minute ‘one-pot’ diagnostic test to observe the levels of 46 different key biomarkers. This test was validated using two separate dementia centre cohorts.
Dr Wendy Heywood who led the study is funded by the NIHR BRC as a Senior Research Associate in Translational Biomarker Discovery.
Gene therapy offers potential to extend lives of children with rare immune disorder
Children have had their lives changed by a ground-breaking gene therapy treatment at Great Ormond Street Hospital for a rare immunodeficiency.
Cutting-edge genomic technology saves girl from rare brain infection
Great Ormond Street Hospital has launched the UK’s first accredited ‘metagenomics’ testing service, that allows clinicians to identify infections that are otherwise undetectable.
New research analyses key immune cell
A new study led by researchers at University College London Great Ormond Street Institute of Child Health has found that women have a higher proportion of key immune cells between puberty and menopause.
First patient treated with groundbreaking gene therapy trial
A baby boy born with a rare condition has become the first in the world to be treated with a new, potentially lifechanging, investigational gene therapy on a clinical trial at Great Ormond Street Hospital (GOSH).